| Literature DB >> 18819779 |
Jui-Hsiu Tsai1, Pinchen Yang, Cheng-Chung Chen, Weilum Chung, Tze-Chun Tang, Shing-Yaw Wang, Jong-Kang Liu.
Abstract
Zolpidem, a non-benzodiazepine hypnotic of the imidazopyridine class, is very effective in treating insomnia with previous claims of little adverse effects. However, zolpidem-induced somnambulism and amnesic sleep-related behavioral problems were begun to be reported in literature but no systemic investigation has been undertaken in non-Western cultures. In our current retrospective survey, 5.1% (13 out of 255) of Taiwanese patients reported change in sleep-related behavior as adverse effects. This serves as a reminder for clinicians to inquire regarding any unusual behavior of parasomniac activities when prescribing zolpidem.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18819779 DOI: 10.1016/j.euroneuro.2008.08.007
Source DB: PubMed Journal: Eur Neuropsychopharmacol ISSN: 0924-977X Impact factor: 4.600